Literature DB >> 26422655

Sorafenib-Induced Eruption Mimicking Erythema Multiforme.

Dominique C Pichard1, Adela R Cardones2, Emily Y Chu3, William L Dahut4, Heidi H Kong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26422655      PMCID： PMC5687976          DOI： 10.1001/jamadermatol.2015.2930

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.

Authors:  M Kodaira; S Takahashi; K Takeuchi; T Yuasa; T Saotome; J Yonese; I Fukui; K Hatake
Journal:  Ann Oncol       Date:  2010-07       Impact factor: 32.976

2.  Sorafenib-induced erythema multiforme.

Authors:  Jennifer L MacGregor; David N Silvers; Marc E Grossman; William H Sherman
Journal:  J Am Acad Dermatol       Date:  2007-01-22       Impact factor: 11.527

Review 3.  Sorafenib-induced erythema multiforme: three cases.

Authors:  Mio Namba; Yuichiro Tsunemi; Makoto Kawashima
Journal:  Eur J Dermatol       Date:  2011 Nov-Dec       Impact factor: 3.328

4.  Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma.

Authors:  Masaomi Ikeda; Tetsuo Fujita; Sumiyuki Mii; Ken-ichi Tanabe; Ken-ichi Tabata; Kazumasa Matsumoto; Takefumi Satoh; Masatsugu Iwamura
Journal:  Jpn J Clin Oncol       Date:  2012-07-10       Impact factor: 3.019

5.  Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.

Authors:  Cemal Bilaç; Talha Müezzinoğlu; Aylin Türel Ermertcan; Tuba Celebi Kayhan; Gökhan Temeltaş; Serap Oztürkcan; Peyker Temiz
Journal:  Cutan Ocul Toxicol       Date:  2009       Impact factor: 1.820

6.  Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.

Authors:  Julien Autier; Bernard Escudier; Janine Wechsler; Alain Spatz; Caroline Robert
Journal:  Arch Dermatol       Date:  2008-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.